Form 4 for ATEX Anterix Inc.
Accepted 2023-12-04 00:00:00 ET · period of report 2023-11-30 · accession 0001209191-23-057315 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-04 | 2023-11-30 | ATEX | Ashe Gena L | CLO, Corp Sec | S - Sale | $32.05 | -936 | 20.2K | -4% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | S | D | 936 | $32.05 | 20,227 | D | — | — | (F1) This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $32.05 to $32.07. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |